These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 16629854

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies.
    Sarwar N, Sattar N, Gudnason V, Danesh J.
    Eur Heart J; 2007 Oct; 28(20):2491-7. PubMed ID: 17513304
    [Abstract] [Full Text] [Related]

  • 3. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
    Rasouli M, Kiasari AM.
    Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
    Onat A, Ozhan H, Can G, Hergenç G, Karabulut A, Albayrak S.
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
    [Abstract] [Full Text] [Related]

  • 6. The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men.
    Lind L, Vessby B, Sundström J.
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):406-10. PubMed ID: 16306426
    [Abstract] [Full Text] [Related]

  • 7. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels.
    Marcovina S, Packard CJ.
    J Intern Med; 2006 May; 259(5):437-46. PubMed ID: 16629849
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
    Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Walldius G, Hamsten A, Hellénius ML, Fisher RM.
    Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
    [Abstract] [Full Text] [Related]

  • 10. Adiponectin and coronary heart disease: a prospective study and meta-analysis.
    Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, Danesh J, Whincup PH.
    Circulation; 2006 Aug 15; 114(7):623-9. PubMed ID: 16894037
    [Abstract] [Full Text] [Related]

  • 11. Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome.
    Sierra-Johnson J, Somers VK, Kuniyoshi FH, Garza CA, Isley WL, Gami AS, Lopez-Jimenez F.
    Am J Cardiol; 2006 Nov 15; 98(10):1369-73. PubMed ID: 17134631
    [Abstract] [Full Text] [Related]

  • 12. Apolipoproteins B and AI and the risk of ischemic cerebrovascular events in patients with pre-existing atherothrombotic disease.
    Koren-Morag N, Goldbourt U, Graff E, Tanne D.
    J Neurol Sci; 2008 Jul 15; 270(1-2):82-7. PubMed ID: 18377938
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein B and apolipoprotein AI as predictors of coronary artery disease.
    Sniderman AD.
    Can J Cardiol; 1988 Jul 15; 4 Suppl A():24A-30A. PubMed ID: 3141025
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM).
    Dunder K, Lind L, Zethelius B, Berglund L, Lithell H.
    Am Heart J; 2004 Oct 15; 148(4):596-601. PubMed ID: 15459588
    [Abstract] [Full Text] [Related]

  • 15. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies.
    Ye Z, Song H.
    Eur J Cardiovasc Prev Rehabil; 2008 Feb 15; 15(1):26-34. PubMed ID: 18277182
    [Abstract] [Full Text] [Related]

  • 16. Apolipoproteins A-I and B-markers in coronary risk evaluation.
    Agoston-Coldea L, Zdrenghea D, Pop D, Crăciun A, Rusu ML, Mocan T.
    Rom J Intern Med; 2007 Feb 15; 45(3):251-8. PubMed ID: 18333357
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis.
    Lowe GD, Danesh J, Lewington S, Walker M, Lennon L, Thomson A, Rumley A, Whincup PH.
    Eur Heart J; 2004 Feb 15; 25(3):252-9. PubMed ID: 14972427
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.